Stevanato Group SpA's book value per share for the quarter that ended in Mar. 2025 was MXN114.75.
During the past 12 months, Stevanato Group SpA's average Book Value Per Share Growth Rate was 5.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 14.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 43.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Stevanato Group SpA was 60.00% per year. The lowest was 14.40% per year. And the median was 57.10% per year.
Stevanato Group SpA's current price is MXN444.62. Its book value per share for the quarter that ended in Mar. 2025 was MXN114.75. Hence, today's PB Ratio of Stevanato Group SpA is 3.87.
During the past 7 years, the highest P/B Ratio of Stevanato Group SpA was 18.75. The lowest was 3.21. And the median was 4.93.
Warning Sign:
Stevanato Group SpA stock PB Ratio (=4.57) is close to 1-year high of 4.57.
Stevanato Group SpA Book Value per Share Historical Data
The historical data trend for Stevanato Group SpA's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Stevanato Group SpA's Book Value per Share
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Stevanato Group SpA (MEX:STVN N) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Stevanato Group SpA Book Value per Share Related Terms
Thank you for viewing the detailed overview of Stevanato Group SpA's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEX:STVN N has been successfully added to your 